Contact
searchSearch
HMP Global

Peripheral Arterial Disease Topic Center

Features

Interview
Latest Updates on the SPORTS Trial and HEAL Registry
11/14/2024
At the 2024 Amputation Prevention Symposium, interventional angiologist Thomas Zeller, MD, from the University Heart Center Freiburg–Krozingen in Bad Krozingen, Germany, discussed 2 of his presentations on the SPORTS Registry and the HEAL...
At the 2024 Amputation Prevention Symposium, interventional angiologist Thomas Zeller, MD, from the University Heart Center Freiburg–Krozingen in Bad Krozingen, Germany, discussed 2 of his presentations on the SPORTS Registry and the HEAL...
At the 2024 Amputation...
11/14/2024
Vascular Disease Management
Jos van den Berg, MD, PhD
CLI Global Society
What's New With the European Chapter of the CLI Global Society
11/13/2024
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at...
11/13/2024
Vascular Disease Management
Case Report
Occluded Tibiopedal Access to Cross and Treat Complex Tibial Artery Occlusive Disease in a Patient With Critical Limb Ischemia
11/08/2024
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been...
11/08/2024
Vascular Disease Management
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Dr Eric Secemsky
Sponsored Video
The Purpose and Value of the ELEGANCE Registry
11/01/2024
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the...
11/01/2024
Vascular Disease Management
Abigail Mize
CLI Global Society
Why You Should Join the Critical Limb Ischemia Global Society
11/01/2024
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee...
11/01/2024
Vascular Disease Management

Videos

Jos van den Berg, MD, PhD
CLI Global Society
What's New With the European Chapter of the CLI Global Society
11/13/2024
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at...
11/13/2024
Vascular Disease Management
Dr Eric Secemsky
Sponsored Video
The Purpose and Value of the ELEGANCE Registry
11/01/2024
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the...
11/01/2024
Vascular Disease Management
Abigail Mize
CLI Global Society
Why You Should Join the Critical Limb Ischemia Global Society
11/01/2024
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee...
11/01/2024
Vascular Disease Management
Dr Katzen
CLI Global Society
Join the Critical Limb Ischemia Global Society!
11/01/2024
CLI Global Society President Barry Katzen, MD, discusses why you should join the Society.
CLI Global Society President Barry Katzen, MD, discusses why you should join the Society.
CLI Global Society President...
11/01/2024
Vascular Disease Management
Dr Fadi Saab
CLI Global Society
The CLI Global Society Publications Committee: Challenging the Status Quo
11/01/2024
Learn about the CLI Society Publications Committee and how their work is changing the way patients with CLI are treated.
Learn about the CLI Society Publications Committee and how their work is changing the way patients with CLI are treated.
Learn about the CLI Society...
11/01/2024
Vascular Disease Management
Dr Tahara
AMP 2024
First-in-Human Case for SLT IVUS Support Crossing Catheter in Complex CLTI Cases With EUS Guidance
09/19/2024
Watch as Dr. Bob Tahara discusses his AMP 2024 presentation.
Watch as Dr. Bob Tahara discusses his AMP 2024 presentation.
Watch as Dr. Bob Tahara...
09/19/2024
Vascular Disease Management
Dr Craig Walker
AMP 2024
The Gore® Viabahn® Stent Graft in the Superficial Femoral Artery for In-Stent Restenosis
09/19/2024
In this video, Dr. Craig Walker discusses his presentation at AMP 2024 on how the Gore Viabahn stent graft is used for in-stent restenosis.
In this video, Dr. Craig Walker discusses his presentation at AMP 2024 on how the Gore Viabahn stent graft is used for in-stent restenosis.
In this video, Dr. Craig Walker...
09/19/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
LIFE-BTK Further Analysis; 12-month RESOLV Data
09/18/2024
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP...
09/18/2024
Vascular Disease Management
Dr Thomas Zeller
AMP 2024
SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update
09/18/2024
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller...
09/18/2024
Vascular Disease Management
Dr. Michael Siah
AMP 2024
ZilverPASS 5-year Results; Deep Vein Arterialization: History and Rationale
09/17/2024
Watch as Dr. Michael Siah discusses 2 of his AMP 2024 presentations on ZilverPASS and DVA.
Watch as Dr. Michael Siah discusses 2 of his AMP 2024 presentations on ZilverPASS and DVA.
Watch as Dr. Michael Siah...
09/17/2024
Vascular Disease Management
Jos van den Berg, MD, PhD
CLI Global Society
What's New With the European Chapter of the CLI Global Society
11/13/2024
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at...
11/13/2024
Vascular Disease Management
Dr Eric Secemsky
Sponsored Video
The Purpose and Value of the ELEGANCE Registry
11/01/2024
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the...
11/01/2024
Vascular Disease Management
Abigail Mize
CLI Global Society
Why You Should Join the Critical Limb Ischemia Global Society
11/01/2024
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee...
11/01/2024
Vascular Disease Management
Dr Katzen
CLI Global Society
Join the Critical Limb Ischemia Global Society!
11/01/2024
CLI Global Society President Barry Katzen, MD, discusses why you should join the Society.
CLI Global Society President Barry Katzen, MD, discusses why you should join the Society.
CLI Global Society President...
11/01/2024
Vascular Disease Management
Dr Fadi Saab
CLI Global Society
The CLI Global Society Publications Committee: Challenging the Status Quo
11/01/2024
Learn about the CLI Society Publications Committee and how their work is changing the way patients with CLI are treated.
Learn about the CLI Society Publications Committee and how their work is changing the way patients with CLI are treated.
Learn about the CLI Society...
11/01/2024
Vascular Disease Management
Gore Minimizing Air
Video
When Used as Recommended, Gore TEVAR Solutions Facilitate a Means for Minimizing Air
11/01/2024
Watch this video to learn more!
Watch this video to learn more!
Watch this video to learn more!
11/01/2024
Vascular Disease Management
Dr Tahara
AMP 2024
First-in-Human Case for SLT IVUS Support Crossing Catheter in Complex CLTI Cases With EUS Guidance
09/19/2024
Watch as Dr. Bob Tahara discusses his AMP 2024 presentation.
Watch as Dr. Bob Tahara discusses his AMP 2024 presentation.
Watch as Dr. Bob Tahara...
09/19/2024
Vascular Disease Management
Dr Craig Walker
AMP 2024
The Gore® Viabahn® Stent Graft in the Superficial Femoral Artery for In-Stent Restenosis
09/19/2024
In this video, Dr. Craig Walker discusses his presentation at AMP 2024 on how the Gore Viabahn stent graft is used for in-stent restenosis.
In this video, Dr. Craig Walker discusses his presentation at AMP 2024 on how the Gore Viabahn stent graft is used for in-stent restenosis.
In this video, Dr. Craig Walker...
09/19/2024
Vascular Disease Management
Dr Bret Wiechmann
AMP 2024
OEIS National Registry: An Update on CLI Patients and Complications
09/18/2024
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann...
09/18/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
LIFE-BTK Further Analysis; 12-month RESOLV Data
09/18/2024
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
In this video recorded at AMP...
09/18/2024
Vascular Disease Management

Abstracts

Atherectomy Adjuvant Balloon Angioplasty versus Balloon Angioplasty Alone in the Treatment of Peripheral Artery Disease
B. C. Cronquist, S. Gutti, M. Rahimi, D. Scher
01/12/2023
Scientific Abstracts
Abstracts From the Amputation Prevention Symposium (AMP), August 17-20, 2022, Chicago, Illinois
09/20/2022
Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention. 
Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention. 
Read the abstracts that were...
09/20/2022
Vascular Disease Management
Outcomes of Surgical Revascularization for Acute Limb Ischemia in COVID-19 Patients Compared With a Non-Infected Cohort
Purpose: Below-knee amputation (BKA), either at the time of creation or after use, in patients with severe peripheral arterial disease (PAD) is complicated, with tissue necrosis leading t...
09/13/2022
The Impact of Reducing Hospitalizations and Amputations in Patients With Diabetic Foot Ulcers
Purpose: In the United States, it is estimated that 6.5 million people over the age of 40 have peripheral arterial disease (PAD). Radiologists examine computed tomography angiography (CTA...
09/13/2022
Crossover of a Complex CTO Lesion Using the Double-Crossing Flossing Technique
Purpose: Gold standard treatment for occlusive lesions of the common femoral artery (CFA) used to be endarterectomy. In recent years, interest for endovascular treatment of the CFA has be...
09/13/2022
Atherectomy With Drug-Eluting Balloon for Common Femoral Artery Occlusive Disease: Short-Term Experience
Purpose: Chronic limb-threatening ischemia has associated morbidity, mortality, and impact on quality of life. This endovascular case had a high-complexity target path anatomy with retrog...
09/13/2022
Dealing With Calcium: A Case Report
Purpose: We report the 24-month outcomes of the PROMISE I early US feasibility study (EFS) after treatment of no-option chronic limb-threatening ischemia (CLTI) with Transcatheter Arteria...
09/13/2022
36-Month Results From the Tack Optimized Balloon Angioplasty II Below-the-Knee Study
Purpose: The purpose of this study was analysis of clinical characteristics and results of surgical revascularization in patients with acute limb ischemia (ALI) and COVID-19, compared wit...
09/13/2022
Internal Iliac Artery Revascularization to Save an Above-the-Knee Stump: Case Report
Purpose: Poor stump healing concerns a significant number of patients. It can be due to lack of vascularization or infection.
09/13/2022
The Circle of Care: The Multidisciplinary Approach to Limb Salvage, Acute Limb Ischemia: Case Presentation
Purpose: Acute limb ischemia (ALI) occurs with an abrupt interruption of blood flow to the extremity and a sudden decrease in limb perfusion, threatening the limb viability. The  incidenc...
09/13/2022
Percutaneous Endoluminal Bypass for Lower Extremity Perfusion in High-Risk Nonsurgical Candidates
Kailin Opella, Andrew Ibrahim, Vivie Tran, Annmarie Farag, Minnie Tran, Mohammad Ansari PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, Texas Introducti...
07/25/2024
Utilization of VBX Expandable Covered Stents in Severe Calcified Aortoiliac Disease to Perform a Mini-EVAR
Subash Swarna, Seena Firouzbakht, Vivie Tran, Amber Hernandez, Hoang Ho, Leigh A. Jenkins, MD, Mohammad M. Ansari, MD  PAD Center of Excellence, Texas Tech University Health Sciences Cen...
07/25/2024
Utilization of Intravascular Ultrasound in the May-Thurner Syndrome: A case series
Vivie Tran, Alistair Disraeli, Nate Fernandez, Karter Morris, Hoang Ho, Dixon Santana, MD, Mohammad M. Ansari, MD PAD Center of Excellence, Texas Tech University Health Sciences Center, ...
07/25/2024
Evaluating ChatGPT's Role in Interventional Cardiology: Assessing Responses Related to CAD and STEMI in PAD Patients
Vivie Tran, Hoang Ho, Steven Daley, Simon Williams, MD, Aliakbar Arvandi, MD, Mohammad M. Ansari, MD PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, ...
07/25/2024
Evaluation of the Utility of ChatGPT Responses In Addressing the Diagnosis and Queries Related to Pulmonary Embolism
Vivie Tran, Hoang Ho, Subash Swarna, Andrew Ibrahim, Minnie Tran, Steven Daley, Simon Williams, MD, Mohammad M. Ansari, MD PAD Center of Excellence, Texas Tech University Health Sciences...
07/25/2024
Addressing Venous Thromboembolisms in Cancer Patients with Urgency and Utilizing Combo Therapy (Penumbra with EKOS) in Treatment of Patients with Submassive Pulmonary Embolism
Sachi Khemka, Hannah Seo, Vivie Tran, Kailin Opella, Esther Burns, Hoang Ho, Marina Iskandir, MD, Mohammad M. Ansari, MD PAD Center of Excellence, Texas Tech University Health Sciences C...
07/25/2024
Image-Guided Mechanical Thrombectomy Utilizing Penumbra Approach for Superior Vena Cava Syndrome as a Last Resort in Stage IV Lung Adenocarcinoma
Vivie Tran, Daniel Xue, Sachi Khemka, Hoang Ho, Mohammad M. Ansari, MD PAD Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, USA
07/25/2024
Racial and Gender Disparities Among Cardiovascular Case Deferment Due to Impacts of the COVID-19 Pandemic
Andrew Ibrahim, Mohamad Altabaa, Zeba Momin, Maryam Niazi, Anthony Bruccoliere, Hoang Ho, Annmarie Farag, Dixon Santana, MD, Mohammad (Mac) Ansari, MD PAD Center of Excellence, Texas Tec...
07/24/2024
Atherectomy as a Crucial Technique for Achieving Peripheral Vascular Intervention in Complete Vessel Occlusion With Severe Calcification
Andrew Ibrahim, Caroline Cushman, Mitchell DeVolder, Hoang Ho, Annmarie Farag, Dixon Santana, MD, Mohammad (Mac) Ansari, MD PAD Center of Excellence, Texas Tech University Health Science...
07/24/2024
ISET 2023 ABSTRACT
Safety and Performance of Aspiration Thrombectomy for Lower Extremity Acute Limb Ischemia: STRIDE Interim Analysis
01/17/2023
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: In a recent...
01/17/2023
Vascular Disease Management

Presentations

Abigail Mize
AMP 2024
Fluoroscopic and Ultrasound Criteria for Patient Selection in DVA
08/17/2024
During her Saturday presentation on DVA Day at AMP, Abigail Mize, BS, RDCS, RVT, from AMize Consulting Services LLC in Grand Rapids, Michigan, provided an overview of selecting patients for DVA based on imaging criteria. 
During her Saturday presentation on DVA Day at AMP, Abigail Mize, BS, RDCS, RVT, from AMize Consulting Services LLC in Grand Rapids, Michigan, provided an overview of selecting patients for DVA based on imaging criteria. 
During her Saturday presentation...
08/17/2024
Vascular Disease Management
Dr Pliagas
AMP 2024
Retrospective Analysis of Peripheral Vascular Intervention Procedural and Safety Outcomes With Utilization of the Glidesheath Slender for Tibiopedal Access
08/16/2024
On Friday, George Pliagas, MD, FACS, FRCSC, from ACV Vascular in Las Vegas, Nevada, presented information about the Glidesheath Slender (Terumo) for tipiopedal access.
On Friday, George Pliagas, MD, FACS, FRCSC, from ACV Vascular in Las Vegas, Nevada, presented information about the Glidesheath Slender (Terumo) for tipiopedal access.
On Friday, George Pliagas, MD,...
08/16/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
Endovascular Treatment of Femoropopliteal Arterial Occlusive Disease With Multiple Sirolimus-Eluting, Balloon-Expandable, Bioresorbable Vascular Scaffolds: The Efemoral Vascular Scaffold System
08/16/2024
In a presentation on Friday morning, Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (Clin Epi) spoke about the Efemoral Vascular Scaffold System, focusing on its innovative approach to treating femoropopliteal arterial occlusive disease.
In a presentation on Friday morning, Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (Clin Epi) spoke about the Efemoral Vascular Scaffold System, focusing on its innovative approach to treating femoropopliteal arterial occlusive disease.
In a presentation on Friday...
08/16/2024
Vascular Disease Management
Dr Mazin Foteh
AMP 2024
Reperfusion Injury vs Compartment Syndrome: Differential Diagnosis and Management
08/15/2024
On Thursday afternoon, Mazin Foteh, MD, provided an in-depth examination of reperfusion injury and compartment syndrome, focusing on their differential diagnosis and management strategies.
On Thursday afternoon, Mazin Foteh, MD, provided an in-depth examination of reperfusion injury and compartment syndrome, focusing on their differential diagnosis and management strategies.
On Thursday afternoon, Mazin...
08/15/2024
Vascular Disease Management
Dr Kevin Rogers
AMP 2024
The Potential Value of Anticoagulation/Anti-Platelet Therapy in CLTI Patients
08/15/2024
On Thursday afternoon, R. Kevin Rogers, MD, spoke about the role of antithrombotic therapy in managing patients with CLTI, particularly those undergoing lower extremity revascularization.
On Thursday afternoon, R. Kevin Rogers, MD, spoke about the role of antithrombotic therapy in managing patients with CLTI, particularly those undergoing lower extremity revascularization.
On Thursday afternoon, R. Kevin...
08/15/2024
Vascular Disease Management
Dr Sonya Noor
AMP 2024
The Logic Behind Leaving Nothing Behind
08/15/2024
During the “Vessel Preparation for CLI” session on Thursday morning. Sonya Noor, MD, from the Gates Vascular Institute in Buffalo, New York, gave a presentation that focused on the strategic use of atherectomy in vascular interventions,...
During the “Vessel Preparation for CLI” session on Thursday morning. Sonya Noor, MD, from the Gates Vascular Institute in Buffalo, New York, gave a presentation that focused on the strategic use of atherectomy in vascular interventions,...
During the “Vessel Preparation...
08/15/2024
Vascular Disease Management
Dr Caroline Fife
AMP 2024
Elevate the CLI Patient’s Voice: Why It Is So Important to Do the Right Thing
08/14/2024
During the Wednesday afternoon CLI Wound session at AMP, Caroline E. Fife, MD, from Baylor College of Medicine in Houston, Texas, delivered a thought-provoking presentation on elevating the CLI patient’s voice and doing the right thing. She...
During the Wednesday afternoon CLI Wound session at AMP, Caroline E. Fife, MD, from Baylor College of Medicine in Houston, Texas, delivered a thought-provoking presentation on elevating the CLI patient’s voice and doing the right thing. She...
During the Wednesday afternoon...
08/14/2024
Vascular Disease Management
ADA logo
AMP 2024
Update on the ADA’s Amputation Prevention Alliance
08/14/2024
On Wednesday morning, Chris Fox, senior vice president of external affairs at the American Diabetes Association (ADA), presented the latest information on the ADA’s Amputation Prevention Alliance (APA). 
On Wednesday morning, Chris Fox, senior vice president of external affairs at the American Diabetes Association (ADA), presented the latest information on the ADA’s Amputation Prevention Alliance (APA). 
On Wednesday morning, Chris Fox,...
08/14/2024
Vascular Disease Management
Dr Laiq Raja
AMP 2024
How to Manage Complex CLI Patients With Wounds in an Outpatient Program
08/14/2024
At Wednesday’s session on CLI in 2024, Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex critical limb ischemia (CLI) patients with wounds in an outpatient...
At Wednesday’s session on CLI in 2024, Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex critical limb ischemia (CLI) patients with wounds in an outpatient...
At Wednesday’s session on CLI in...
08/14/2024
Vascular Disease Management
Dr Yolanda Bryce
AMP 2024
What Is the Goal of CLI Therapy? Arterial Patency vs. Wound Healing vs. Limb Salvage
08/14/2024
On the first day of AMP 2024, Yolanda Bryce, MD, RPVI, from Memorial Sloan Kettering Cancer Center in New York, spoke about the complex goals of critical limb ischemia (CLI) therapy, emphasizing the nuanced balance between achieving...
On the first day of AMP 2024, Yolanda Bryce, MD, RPVI, from Memorial Sloan Kettering Cancer Center in New York, spoke about the complex goals of critical limb ischemia (CLI) therapy, emphasizing the nuanced balance between achieving...
On the first day of AMP 2024,...
08/14/2024
Vascular Disease Management
Abigail Mize
AMP 2024
Fluoroscopic and Ultrasound Criteria for Patient Selection in DVA
08/17/2024
During her Saturday presentation on DVA Day at AMP, Abigail Mize, BS, RDCS, RVT, from AMize Consulting Services LLC in Grand Rapids, Michigan, provided an overview of selecting patients for DVA based on imaging criteria. 
During her Saturday presentation on DVA Day at AMP, Abigail Mize, BS, RDCS, RVT, from AMize Consulting Services LLC in Grand Rapids, Michigan, provided an overview of selecting patients for DVA based on imaging criteria. 
During her Saturday presentation...
08/17/2024
Vascular Disease Management
Dr Pliagas
AMP 2024
Retrospective Analysis of Peripheral Vascular Intervention Procedural and Safety Outcomes With Utilization of the Glidesheath Slender for Tibiopedal Access
08/16/2024
On Friday, George Pliagas, MD, FACS, FRCSC, from ACV Vascular in Las Vegas, Nevada, presented information about the Glidesheath Slender (Terumo) for tipiopedal access.
On Friday, George Pliagas, MD, FACS, FRCSC, from ACV Vascular in Las Vegas, Nevada, presented information about the Glidesheath Slender (Terumo) for tipiopedal access.
On Friday, George Pliagas, MD,...
08/16/2024
Vascular Disease Management
Dr Ramon Varcoe
AMP 2024
Endovascular Treatment of Femoropopliteal Arterial Occlusive Disease With Multiple Sirolimus-Eluting, Balloon-Expandable, Bioresorbable Vascular Scaffolds: The Efemoral Vascular Scaffold System
08/16/2024
In a presentation on Friday morning, Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (Clin Epi) spoke about the Efemoral Vascular Scaffold System, focusing on its innovative approach to treating femoropopliteal arterial occlusive disease.
In a presentation on Friday morning, Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (Clin Epi) spoke about the Efemoral Vascular Scaffold System, focusing on its innovative approach to treating femoropopliteal arterial occlusive disease.
In a presentation on Friday...
08/16/2024
Vascular Disease Management
Dr Mazin Foteh
AMP 2024
Reperfusion Injury vs Compartment Syndrome: Differential Diagnosis and Management
08/15/2024
On Thursday afternoon, Mazin Foteh, MD, provided an in-depth examination of reperfusion injury and compartment syndrome, focusing on their differential diagnosis and management strategies.
On Thursday afternoon, Mazin Foteh, MD, provided an in-depth examination of reperfusion injury and compartment syndrome, focusing on their differential diagnosis and management strategies.
On Thursday afternoon, Mazin...
08/15/2024
Vascular Disease Management
Dr Kevin Rogers
AMP 2024
The Potential Value of Anticoagulation/Anti-Platelet Therapy in CLTI Patients
08/15/2024
On Thursday afternoon, R. Kevin Rogers, MD, spoke about the role of antithrombotic therapy in managing patients with CLTI, particularly those undergoing lower extremity revascularization.
On Thursday afternoon, R. Kevin Rogers, MD, spoke about the role of antithrombotic therapy in managing patients with CLTI, particularly those undergoing lower extremity revascularization.
On Thursday afternoon, R. Kevin...
08/15/2024
Vascular Disease Management
Dr Sonya Noor
AMP 2024
The Logic Behind Leaving Nothing Behind
08/15/2024
During the “Vessel Preparation for CLI” session on Thursday morning. Sonya Noor, MD, from the Gates Vascular Institute in Buffalo, New York, gave a presentation that focused on the strategic use of atherectomy in vascular interventions,...
During the “Vessel Preparation for CLI” session on Thursday morning. Sonya Noor, MD, from the Gates Vascular Institute in Buffalo, New York, gave a presentation that focused on the strategic use of atherectomy in vascular interventions,...
During the “Vessel Preparation...
08/15/2024
Vascular Disease Management
Dr Caroline Fife
AMP 2024
Elevate the CLI Patient’s Voice: Why It Is So Important to Do the Right Thing
08/14/2024
During the Wednesday afternoon CLI Wound session at AMP, Caroline E. Fife, MD, from Baylor College of Medicine in Houston, Texas, delivered a thought-provoking presentation on elevating the CLI patient’s voice and doing the right thing. She...
During the Wednesday afternoon CLI Wound session at AMP, Caroline E. Fife, MD, from Baylor College of Medicine in Houston, Texas, delivered a thought-provoking presentation on elevating the CLI patient’s voice and doing the right thing. She...
During the Wednesday afternoon...
08/14/2024
Vascular Disease Management
ADA logo
AMP 2024
Update on the ADA’s Amputation Prevention Alliance
08/14/2024
On Wednesday morning, Chris Fox, senior vice president of external affairs at the American Diabetes Association (ADA), presented the latest information on the ADA’s Amputation Prevention Alliance (APA). 
On Wednesday morning, Chris Fox, senior vice president of external affairs at the American Diabetes Association (ADA), presented the latest information on the ADA’s Amputation Prevention Alliance (APA). 
On Wednesday morning, Chris Fox,...
08/14/2024
Vascular Disease Management
Dr Laiq Raja
AMP 2024
How to Manage Complex CLI Patients With Wounds in an Outpatient Program
08/14/2024
At Wednesday’s session on CLI in 2024, Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex critical limb ischemia (CLI) patients with wounds in an outpatient...
At Wednesday’s session on CLI in 2024, Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex critical limb ischemia (CLI) patients with wounds in an outpatient...
At Wednesday’s session on CLI in...
08/14/2024
Vascular Disease Management
Dr Yolanda Bryce
AMP 2024
What Is the Goal of CLI Therapy? Arterial Patency vs. Wound Healing vs. Limb Salvage
08/14/2024
On the first day of AMP 2024, Yolanda Bryce, MD, RPVI, from Memorial Sloan Kettering Cancer Center in New York, spoke about the complex goals of critical limb ischemia (CLI) therapy, emphasizing the nuanced balance between achieving...
On the first day of AMP 2024, Yolanda Bryce, MD, RPVI, from Memorial Sloan Kettering Cancer Center in New York, spoke about the complex goals of critical limb ischemia (CLI) therapy, emphasizing the nuanced balance between achieving...
On the first day of AMP 2024,...
08/14/2024
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
CLI/CLTI
Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry
06/19/2024

Micro Medical Solutions Press Release

Micro Medical Solutions Press Release...
Micro Medical Solutions is excited to announce that it has achieved a major milestone with the enrollment of its 200th patient in the HEAL Registry, which is focused on gathering real-world evidence using its MicroStent technology for...
Micro Medical Solutions is excited to announce that it has achieved a major milestone with the enrollment of its 200th patient in the HEAL Registry, which is focused on gathering real-world evidence using its MicroStent technology for...
Micro Medical Solutions is...
06/19/2024
Cath Lab Digest
Critical Limb-Threatening Ischemia
Terrebonne General and CIS are First in the Gulf South to Use the New FDA-Approved Esprit™ System to Treat Artery Disease Below the Knee
06/04/2024

CIS News Release

CIS News Release
Houma, LA – Terrebonne General Health System (Terrebonne General) and Cardiovascular Institute of the South (CIS) are the first in the Gulf South and only one of five in the country to use the new FDA-approved Esprit™ BTK (Below the Knee)...
Houma, LA – Terrebonne General Health System (Terrebonne General) and Cardiovascular Institute of the South (CIS) are the first in the Gulf South and only one of five in the country to use the new FDA-approved Esprit™ BTK (Below the Knee)...
Houma, LA – Terrebonne General...
06/04/2024
Vascular Disease Management
PAD
Cardiovascular Institute of the South Is First in the Country to Use New PTA Balloon to Treat Vascular Disease in the Legs
05/28/2024

CIS Press Release

CIS Press Release
MAY 24, 2024 – HOUMA – Cardiovascular Institute of the South (CIS) is the first in the country to use the Aperta NSE™ (Novel Scoring Elements) PTA (Percutaneous Transluminal Angioplasty) Balloon to treat peripheral artery disease (PAD) in...
MAY 24, 2024 – HOUMA – Cardiovascular Institute of the South (CIS) is the first in the country to use the Aperta NSE™ (Novel Scoring Elements) PTA (Percutaneous Transluminal Angioplasty) Balloon to treat peripheral artery disease (PAD) in...
MAY 24, 2024 – HOUMA –...
05/28/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use